ANIX

Anixa Biosciences (ANIX)

About Anixa Biosciences (ANIX)

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Details

Daily high
$3.39
Daily low
$3.10
Price at open
$3.35
52 Week High
$5.46
52 Week Low
$2.07
Market cap
111.3M
Dividend yield
0.00%
Volume
433,620
Avg. volume
298,201
P/E ratio
-9.81

Anixa Biosciences News

Details

Daily high
$3.39
Daily low
$3.10
Price at open
$3.35
52 Week High
$5.46
52 Week Low
$2.07
Market cap
111.3M
Dividend yield
0.00%
Volume
433,620
Avg. volume
298,201
P/E ratio
-9.81